Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

First Spectralis OCT2 with OCT angiography installed at Queen's University, Belfast

Heidelberg Engineering’s device to be used in Northern Ireland Cohort for Longitudinal Study of Ageing, looking at diabetes, AMD and glaucoma

Ruth Hogg

The UK’s first ‘Spectralis OCT2,’ with optical coherence tomography (OCT) angiography, has been installed at Queen’s University in Belfast.

The Heidelberg Engineering device will be used in the Northern Ireland Cohort for Longitudinal study of Ageing (NICOLA), which is following the lives of 8,500 people over 50, as they grow older.

“The TruTrack active eye-tracking feature in Spectralis will create a detailed retinal map of each patient,” explained Heidelberg Engineering’s director of clinical services, Christopher Mody.

“It will allow the automatic placement of follow-up scans in precisely the same anatomical location, so the clinician can observe the smallest changes in the patient’s eyes as they age,” he added.

Lecturer at the Centre for Experimental Medicine at the university, Dr Ruth Hogg (pictured), said: “We are excited to include the Spectralis OCT angiography module in the NICOLA add-on studies to look at the microvasculature within the retina and choroid, non-invasively.

“These consist of a second visit by NICOLA participants on the basis of features we see in their main study visit, and will include a study of normal ageing, diabetes, aged-related macular degeneration and glaucoma.”

It is hoped that the data gathered in the study will provide a basis for future government policy to help Northern Ireland meet the demands of an ageing population.

Advertisement